2021
DOI: 10.1016/j.heliyon.2021.e06657
|View full text |Cite
|
Sign up to set email alerts
|

Design and identification of novel annomontine analogues against SARS-CoV-2: An in-silico approach

Abstract: Aims: COVID-19 has currently emerged as the major global pandemic affecting the lives of people across the globe. It broke out from Wuhan Province of China, first reported to WHO on 31 st December 2019 as "Pneumonia of unknown cause". Over time more people were infected with this virus, and the only tactic to ensure safety was to take precautionary measures due to the lack of any effective treatment or vaccines. As a result of unavailability of desired efficacy for previously repurposed drugs, exploring novel … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 60 publications
(60 reference statements)
1
7
0
Order By: Relevance
“…More than 23 annomontine analogs, which represent a special class of β-carboline, were designed and docked against multiple SARS-CoV-2. Based on docking scores, the binding affinities of these annomontine derivatives were better compared to hydroxycholoquine [ 57 ]. While the potential of different β-carbolines in binding to several SARS-CoV-2 proteins has been demonstrated computationally, our results are the first to show direct in vitro experimental evidence against SARS-CoV-2 M pro .…”
Section: Discussionmentioning
confidence: 99%
“…More than 23 annomontine analogs, which represent a special class of β-carboline, were designed and docked against multiple SARS-CoV-2. Based on docking scores, the binding affinities of these annomontine derivatives were better compared to hydroxycholoquine [ 57 ]. While the potential of different β-carbolines in binding to several SARS-CoV-2 proteins has been demonstrated computationally, our results are the first to show direct in vitro experimental evidence against SARS-CoV-2 M pro .…”
Section: Discussionmentioning
confidence: 99%
“…N -heterocyclic compounds have become progressively in demand for their exclusive structural identity exhibiting myriad medicinal and pharmaceutical activities [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ]. The saturated and unsaturated N -heterocyclic analogues have exceptionally interesting architecture for drug design and development [ 7 , 17 , 18 , 19 , 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…Because CSCs are difficult to identify, there is a need to identify stem cell markers. In this study, we selected the two most common types of gynecological cancers affecting women worldwide; breast cancer, and cervical cancer to analyze the stem cell markers, and target the most significant stem cell marker by novel plant-based metabolites and their derivatives like hydroxyl-piperloungumines, Coumaperine, annomontine, curcumin derivatives and 6,6'-Dihydroxythiobinupharidine (DTBN) [6][7][8][9][10] .…”
Section: Introductionmentioning
confidence: 99%